![John Schroer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Schroer
Directeur Financier/CFO chez
ALUMIS INC.
Fortune : - $ au 31/05/2026
Profil
John R.
Schroer is currently an Independent Director at Azitra, Inc. since 2023 and Chief Financial Officer at Alumis, Inc. since 2022.
Formerly, Mr. Schroer was Director of Research at INVESCO Funds Group, Inc. in 2001; Director & Head-Healthcare and Director & Portfolio Manager at Allianz Global Investors GmbH and Allianz Global Investors U.S.
LLC from 2014 to 2018; Analyst at TCW Asset Management Co. LLC in 1993; President at Itros Capital Management LLC from 2004 to 2005; Analyst at HealthCor Management LP in 2008; CFO, Treasurer & Principal Accounting Officer at Translate Bio, Inc. from 2018 to 2020; President & Chief Investment Officer at Schroer Capital LP from 2009 to 2013; and Chief Financial Officer at Arsenal Biosciences, Inc. from 2021 to 2022.
Education includes undergraduate and MBAistration degrees from the University of Wisconsin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALUMIS INC. -.--% | 26/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
AZITRA INC -.--% | 24/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de John Schroer
| Sociétés | Poste | Début |
|---|---|---|
| AZITRA, INC. | Directeur/Membre du Conseil | 01/06/2023 |
| ALUMIS INC. | Directeur Financier/CFO | 01/05/2022 |
Anciens postes connus de John Schroer
| Sociétés | Poste | Fin |
|---|---|---|
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Develops cellular drug discovery tools to provide medicines for cancer treatment and operates cell manufacturing platform | Directeur Financier/CFO | 01/02/2022 |
| TRANSLATE BIO, INC. | Directeur Financier/CFO | 27/12/2020 |
Allianz Global Investors U.S. LLC
 Allianz Global Investors U.S. LLC Investment ManagersFinance AllianzGI US manages client portfolios (directly or through model delivery and wrap fee programs) using traditional and systematic processes across various investment strategies. The firm offers an array of US equity strategies that vary across style and market-cap ranges. Their high yield bond and convertibles strategies employ a fundamental bottom-up process that seeks the early identification of high yield issuers that exhibit the potential for improving fundamental characteristics. AllianzGI US employs rigorous fundamental research and capital structure analysis to construct portfolios that consist of the best companies from a risk/return standpoint. They also offer alternative investment strategies that are designed to achieve absolute return, alpha enhancement and beta hedging. | Head-Equity Investments | 18/05/2018 |
Allianz Global Investors GmbH
 Allianz Global Investors GmbH Investment ManagersFinance AGI is an active manager which conducts in-house proprietary research to invest in public equity and fixed-income markets globally. The firm offers a range of investment strategies and styles. They make equity investments in value and growth stocks of companies across market-caps and typically invest in US convertibles, US high yield bonds and mortgage-backed securities for fixed-income. AGI also makes alternative investments. They have a strong focus on superior alpha-creation and modern risk management techniques are a primary concern. | Directeur/Membre du Conseil | 01/04/2018 |
Schroer Capital LP
 Schroer Capital LP Investment ManagersFinance Schroer Capital manages the Schroer Capital Partners LP, a long/short equity hedge fund. The fund employs a fundamental research approach to select investments in the stocks of US healthcare companies. Schroer Capital has particular expertise in short selling. | President | 01/12/2013 |
Formation de John Schroer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
TCW Asset Management Co. LLC
 TCW Asset Management Co. LLC Investment ManagersFinance TCW maintains a value-oriented investment approach and their investment process focuses on preserving capital for their clients. The firm’s integrated top-down and bottom-up investment process emphasizes global and multi-sector diversification to generate attractive risk-adjusted returns from income and capital appreciation. They offer a range of investment strategies across fixed income, equities, and emerging markets. | Finance |
INVESCO Funds Group, Inc.
 INVESCO Funds Group, Inc. Investment ManagersFinance Part of Invesco Ltd., INVESCO Funds Group, Inc. is a company based in Denver, CO. | Finance |
Itros Capital Management LLC
 Itros Capital Management LLC Investment ManagersFinance Itros manages a long/short equity hedge fund focused on the health care sector. | Finance |
HealthCor Management LP
 HealthCor Management LP Investment ManagersFinance HealthCor focuses principally on the global healthcare and life sciences industry. The firm seeks to achieve superior risk-adjusted returns primarily through investments in equity and equity-related instruments where they use a fundamental bottom-up research driven approach to stock selection across the major sub-sectors of healthcare and life sciences including pharmaceuticals, MedTech, biotech and services. | Finance |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allianz Global Investors GmbH
Allianz Global Investors GmbH Investment ManagersFinance AGI is an active manager which conducts in-house proprietary research to invest in public equity and fixed-income markets globally. The firm offers a range of investment strategies and styles. They make equity investments in value and growth stocks of companies across market-caps and typically invest in US convertibles, US high yield bonds and mortgage-backed securities for fixed-income. AGI also makes alternative investments. They have a strong focus on superior alpha-creation and modern risk management techniques are a primary concern. | Finance |
Allianz Global Investors U.S. LLC
Allianz Global Investors U.S. LLC Investment ManagersFinance AllianzGI US manages client portfolios (directly or through model delivery and wrap fee programs) using traditional and systematic processes across various investment strategies. The firm offers an array of US equity strategies that vary across style and market-cap ranges. Their high yield bond and convertibles strategies employ a fundamental bottom-up process that seeks the early identification of high yield issuers that exhibit the potential for improving fundamental characteristics. AllianzGI US employs rigorous fundamental research and capital structure analysis to construct portfolios that consist of the best companies from a risk/return standpoint. They also offer alternative investment strategies that are designed to achieve absolute return, alpha enhancement and beta hedging. | Finance |
Schroer Capital LP
Schroer Capital LP Investment ManagersFinance Schroer Capital manages the Schroer Capital Partners LP, a long/short equity hedge fund. The fund employs a fundamental research approach to select investments in the stocks of US healthcare companies. Schroer Capital has particular expertise in short selling. | Finance |
Azitra, Inc.
 Azitra, Inc. Pharmaceuticals: MajorHealth Technology Operates as an clinical biopharmaceutical company that develops and commercializes therapies for precision dermatology | Health Technology |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Develops cellular drug discovery tools to provide medicines for cancer treatment and operates cell manufacturing platform | Technology Services |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
